scholarly journals Fighting Strategies Against the Novel Coronavirus Pandemic: Impact on Global Economy

2020 ◽  
Vol 8 ◽  
Author(s):  
Bapi Gorain ◽  
Hira Choudhury ◽  
Nagashekhara Molugulu ◽  
Rajani B. Athawale ◽  
Prashant Kesharwani
Keyword(s):  
Disease Transmission ◽  
Global Economy ◽  
World Health ◽  
World Population ◽  
Mortality And Morbidity ◽  
Short Period ◽  
The World ◽  
Treatment Measures ◽  
Novel Coronavirus ◽  
Health Organization

Sudden outbreak of a new pathogen in numbers of pneumonic patients in Wuhan province during December 2019 has threatened the world population within a short period of its occurrence. This respiratory tract–isolated pathogen was initially named as novel coronavirus 2019 (nCoV-2019), but later termed as SARS-CoV-2. The rapid spreading of this infectious disease received the label of pandemic by the World Health Organization within 4 months of its occurrence, which still seeks continuous attention of the researchers to prevent the spread and for cure of the infected patients. The propagation of the disease has been recorded in 215 countries, with more than 25.5 million cases and a death toll of more than 0.85 million. Several measures are taken to control the disease transmission, and researchers are actively engaged in finding suitable therapeutics to effectively control the disease to minimize the mortality and morbidity rates. Several existing potential candidates were explored in the prevention and treatment of worsening condition of COVID-19 patients; however, none of the formulation has been approved for the treatment but used under medical supervision. In this article, a focus has been made to highlight on current epidemiology on the COVID-19 infection, clinical features, diagnosis, and transmission, with special emphasis on treatment measures of the disease at different stages of clinical research and the global economic influence due to this pandemic situation. Progress in the development on vaccine against COVID-19 has also been explored as important measures to immunize people. Moreover, this article is expected to provide information to the researchers, who are constantly combating in the management against this outbreak.

scholarly journals COVID-19; Plague of the 21st Century; Situation Update

2020 ◽  
pp. 11-21
Author(s):  
Mirza Zain Baig ◽  
Zaitoon Zafar ◽  
Abeer Aziz ◽  
Umme Hani Abdullah
Keyword(s):  
Global Economy ◽  
Current Knowledge ◽  
Social Stigma ◽  
World Health ◽  
The Novel ◽  
Comprehensive Review ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Medical Infrastructure

The first known case of COVID-19 caused by the novel coronavirus now known as SARS-CoV-2 occurred in Wuhan, China in late December 2019. In a matter of a few months, it has spread globally to infect more than 500, 000 people and has caused more than 20,000 deaths. It was officially declared a pandemic on March 11, 2020, by the World Health Organization (WHO). To date, it has strained medical infrastructure, stagnated global economy and given rise to social stigma, fear, and racism. In this article, we provide a comprehensive review of our current knowledge and understanding of this new disease.

scholarly journals Detection of Covid-19 Based on Chest Medical Imaging and Artificial Intelligent Techniques: A Review

2021 ◽  
Vol 17 (2) ◽  
pp. 176-182
Author(s):  
Nawres Aref ◽  
Hussain Kareem
Keyword(s):  
Global Economy ◽  
Classification Performance ◽  
World Health ◽  
Global Epidemic ◽  
The World ◽  
Chest X Ray ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Percent Accuracy ◽  
Performance Results

Novel Coronavirus (Covid-2019), which first appeared in December 2019 in the Chinese city of Wuhan. It is spreading rapidly in most parts of the world and becoming a global epidemic. It is devastating, affecting public health, daily life, and the global economy. According to the statistics of the World Health Organization on August 11, the number of cases of coronavirus (Covid-2019) reached nearly 17 million, and the number of infections globally distributed among most European countries and most countries of the Asian continent, and the number of deaths from the Coronavirus reached 700 thousand people around the world. . It is necessary to detect positive cases as soon as possible in order to prevent the spread of this epidemic and quickly treat infected patients. In this paper, the current literature on the methods used to detect Covid is presented. In these studies, the research that used different techniques of artificial intelligence to detect COVID-19 was reviewed as the coevolutionary neural network (ResNet50, ResNet101, ResNet152, InceptionV3, and Inception-ResNetV2) were proposed for the identification of patients infected with coronavirus pneumonia using chest X-ray radiographs By using 5-fold cross validation, three separate binary classifications of four grades (COVID-19, normal (healthy), viral pneumonia and bacterial pneumonia) were introduced. It has been shown that the pre-trained ResNet50 model offers the highest classification performance (96.1 percent accuracy for Dataset-1, 99.5 percent accuracy for Dataset-2, and 99.7 percent accuracy for Dataset-2) based on the performance results obtained.

scholarly journals Inclusive Policymaking Tools: A COVID-19 Pandemic Case Study

2020 ◽  
Vol 17 (01) ◽  
Author(s):  
Ans Irfan ◽  
Ankita Arora ◽  
Christopher Jackson ◽  
Celina Valencia
Keyword(s):  
Best Practices ◽  
United States Of America ◽  
The United States ◽  
World Health ◽  
Mortality And Morbidity ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Equity And Inclusion

World Health Organization (WHO) estimates indicate the United States of America has the highest novel Coronavirus disease (COVID-19) burden in the world, with over 5 million confirmed cases and nearly 165,000 associated deaths as of August 14th, 2020 (WHO 2020). As the COVID-19 mortality and morbidity has disproportionately impacted populations who experience vulnerabilities due to structural issues such as racism (Laurencin and McClinton 2020; Lin II and Money 2020; Martin 2020; Kim et al. 2020), it has become increasingly necessary to take this opportunity and intentionally codify diversity, equity, and inclusion (DEI) practices in the policymaking process. To encourage and facilitate this, we synthesize existing literature to identify best practices that can not only be used to inform COVID-19-related public policy activities but will also continue to inform inclusive policymaking processes in the future. We identify specific tools for policymakers at all levels of government to better operationalize the DEI framework and enact inclusive, equitable public policies as a result.

scholarly journals Forecasting COVID-19 Transmission in India Using Deep Learning Models

2020 ◽  
Vol 10 (2) ◽  
pp. 2044-2055
Keyword(s):  
Transmission Rate ◽  
World Health ◽  
Similar Data ◽  
Slowing Down ◽  
Short Period ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Susceptible Populations ◽  
Near Future

In the past 6 months, the world has come to a standstill due to an escalation in the number of cases of COVID-19. COVID-19 is an infectious disease that was formerly called as 2019-nCoV or the novel Coronavirus 2019. COVID-19 first originated in Wuhan, China, in late December 2019, and subsequently, the World Health Organization declared it as a pandemic on 11th March, 2020. Lack of preparedness for the COVID-19 pandemic has put colossal stress on the healthcare systems of the world’s largest economies. In a short period, the disease has spread to an unexpected number of people due to its high transmission rate and doesn’t show a sign of slowing down in the near future. Estimating the rising number of cases via predictive modeling can help gauge the quantity of various medical amenities required for the treatment of patients as well as protective apparatus for essential workers and susceptible populations. In this paper, we have performed time series forecasting on the publicly available COVID-19 datasets of India using RNNs with LSTM and GRU. Additionally, we also employ the final models for analyzing similar data from different countries.

scholarly journals COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?

2020 ◽  
Author(s):  
Stella Papachristou ◽  
Theano Penlioglou ◽  
Anca Pantea Stoian ◽  
Nikolaos Papanas
Keyword(s):  
Infectious Disease ◽  
World Health ◽  
Respiratory Tract Diseases ◽  
Mortality And Morbidity ◽  
Elderly Individuals ◽  
Sodium Glucose Cotransporter ◽  
The World ◽  
Obesity Hypertension ◽  
Novel Coronavirus ◽  
Health Organization

AbstractNovel coronavirus infectious disease (COVID-19) has been recognised as a pandemic by the World Health Organization (WHO) 1. Mortality and morbidity are higher in elderly individuals and those with comorbidities, such as diabetes mellitus (DM), obesity, hypertension, respiratory tract diseases, coronary heart disease or cancer 1. Indeed, two thirds of individuals who died from COVID-19 had DM in Italy 2.

Current updates on COVID-19 - A review

2020 ◽  
Vol 10 (1) ◽  
pp. 1-8
Author(s):  
Ghotekar D S ◽  
Vishal N Kushare ◽  
Sagar V Ghotekar
Keyword(s):  
World Health Organization ◽  
Common Cold ◽  
Respiratory Diseases ◽  
Gastrointestinal Diseases ◽  
Hubei Province ◽  
World Health ◽  
The World ◽  
The Common ◽  
Novel Coronavirus ◽  
Health Organization

Coronaviruses are a family of viruses that cause illness such as respiratory diseases or gastrointestinal diseases. Respiratory diseases can range from the common cold to more severe diseases. A novel coronavirus outbreak was first documented in Wuhan, Hubei Province, China in December 2019. The World Health Organization (WHO) has declared the coronavirus disease 2019 (COVID-19) a pandemic. A global coordinated effort is needed to stop the further spread of the virus. A novel coronavirus (nCoV) is a new strain that has not been identified in humans previously. Once scientists determine exactly what coronavirus it is, they give it a name (as in the case of COVID-19, the virus causing it is SARS-CoV-2).

An approach to the understanding of the clinical-etiopathological aspect of COVID-19 (SARS-CoV-2)

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 862-869
Author(s):  
Meena Kumari ◽  
Monika Agrawal ◽  
Rakesh Kumar Singh ◽  
Parameswarappa S Byadgi
Keyword(s):  
World Health ◽  
Apical Surface ◽  
Therapy Assessment ◽  
Differentiated Cells ◽  
The World ◽  
Polarized Epithelia ◽  
Well Differentiated ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Epidemiological Characteristics

Currently, the world is facing a health and socioeconomic crisis caused by the novel coronavirus disease COVID-19. On 11 March 2020, the World Health Organization (WHO) has declared this disease as a pandemic. The condition (COVID-19) is an infectious disorder triggered by a newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2. Most of the COVID-19 infected patients will experience mild to moderate respiratory symptoms and recover without any unique therapy. Assessment of the clinical and epidemiological characteristics of SARS-CoV-2 cases suggests the infected patients will not be contagious until the onset of severe symptoms and affects the other organs. Well-differentiated cells of apical airway epithelia communicating with ACE2 were promptly infected to SARS-CoV-2 virus. But the expression of ACE 2 in poorly differentiated epithelia facilitated SARS spike (S) protein-pseudo typed virus entry and it is replicated in polarized epithelia and especially exited via the apical surface. Limiting the transmission of COVID-19 infection & its prevention can be regarded as a hierarchy of controls. In this article, we briefly discuss the most recent advances in respect to aetiology, pathogenesis and clinical progression of the disease COVID-19.

Treatment Options in COVID-19: The Role of Bioavailable Antiviral Ribonucleoside Analog on NHC in vitro

2020 ◽  
Author(s):  
Lara Bittmann
Keyword(s):  
World Health Organization ◽  
Clinical Picture ◽  
Treatment Options ◽  
World Health ◽  
Wuhan City ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

On December 31, 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on January 7, 2020 and was provisionally named "2019-nCoV". This new Coronavirus causes a clinical picture which has received now the name COVID-19. The virus has spread subsequently worldwide and was explained on the 11th of March, 2020 by the World Health Organization to the pandemic.

Critical Insight into the Attributes of Emerging Novel Coronavirus (COVID-19) in India and Across the World

Coronaviruses ◽  
2020 ◽  
Vol 1 (1) ◽  
pp. 49-56
Author(s):  
Gaurav M. Doshi ◽  
Hemen S. Ved ◽  
Ami P. Thakkar
Keyword(s):  
Review Article ◽  
World Health ◽  
Effective Vaccine ◽  
Human Contact ◽  
The World ◽  
Critical Insight ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Insight Into ◽  
Old Drugs

The World Health Organization (WHO) has recently announced the spread of novel coronavirus (nCoV) globally and has declared it a pandemic. The probable source of transmission of the virus, which is from animal to human and human to human contact, has been established. As per the statistics reported by the WHO on 11th April 2020, data has shown that more than sixteen lakh confirmed cases have been identified globally. The reported cases related to nCoV in India have been rising substantially. The review article discusses the characteristics of nCoV in detail with the probability of potentially effective old drugs that may inhibit the virus. The research may further emphasize and draw the attention of the world towards the development of an effective vaccine as well as alternative therapies. Moreover, the article will help to bridge the gap between the new researchers since it’s the current thrust area of research.

The Pandemic of Novel Coronavirus Disease 2019 (COVID-19): Need for an Immediate Action (Preprint)

2020 ◽  
Author(s):  
Mujib Ullah
Keyword(s):  
World Health Organization ◽  
Large Family ◽  
Current Treatment ◽  
World Health ◽  
New Disease ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

UNSTRUCTURED Coronaviruses belong to a large family of viruses. Coronavirus also called COVID-19 is a new disease that has not been previously identified in humans. The World Health Organization has announced that COVID-19 is a pandemic. Currently there is no specific vaccine or treatment for COVID-19. Current treatment for COVID-19 is only supportive (treating the symptoms). There are no antiviral or vaccine options at this time. Therefore, it is time to bring collective efforts to treat or prevent a rapidly evolving pandemic of COVID-19.

Sign in / Sign up

Export Citation Format

Share Document